scispace - formally typeset
J

Jiangang Shen

Researcher at University of Hong Kong

Publications -  179
Citations -  8185

Jiangang Shen is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Neuroprotection & Peroxynitrite. The author has an hindex of 45, co-authored 167 publications receiving 5777 citations. Previous affiliations of Jiangang Shen include Guangzhou University & Academia Sinica.

Papers
More filters
Journal ArticleDOI

Site-2 protease responds to oxidative stress and regulates oxidative injury in mammalian cells

TL;DR: Results suggest that S2P can be a protease responding to oxidative stress and has the function of regulating cellular oxidative injury.
Journal ArticleDOI

Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation.

TL;DR: Wang et al. as mentioned in this paper evaluated the renoprotective effect of BHD on a streptozotocin (STZ)-induced diabetic nephropathy mouse model and explore the potential underlying mechanism in mouse mesangial cells (MCs) treated with high glucose in vitro, followed by screening the active compounds in BHD.
Journal ArticleDOI

Pinosylvin provides neuroprotection against cerebral ischemia and reperfusion injury through enhancing PINK1/Parkin mediated mitophagy and Nrf2 pathway

TL;DR: Pinosylvin exhibited neuroprotective effects by inducing PINK1/Parkin mediated mitophagy to remove damaged mitochondria and activating Nrf2 pathway to ameliorate oxidative stress-induced mitochondrial dysfunction.
Journal ArticleDOI

Targeting Neurogenesis: A Promising Therapeutic Strategy for Post-Stroke Treatment with Chinese Herbal Medicine

TL;DR: Although the precise mechanisms and molecular targets of herbal medicine for neurogenesis are still unclear, current progress at least provides a cue for exploring the therapeutic principles of Chinese herbal medicine and developing new drugs for brain repair after stroke.
Journal ArticleDOI

The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.

TL;DR: It is concluded that the XRCC1 Arg399Gln polymorphism contributes to HCC susceptibility and further large-sample and rigorous studies are needed to validate the findings.